Chad R. Messick

426 total citations
16 papers, 276 citations indexed

About

Chad R. Messick is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Chad R. Messick has authored 16 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Pharmacology and 6 papers in Clinical Biochemistry. Recurrent topics in Chad R. Messick's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Chad R. Messick is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Chad R. Messick collaborates with scholars based in United States, Switzerland and Italy. Chad R. Messick's co-authors include Susan L. Pendland, Christian Reinke, Rose Jung, Geeta Sinha, Piero Olliaro, C.P. Thakur, Keith A. Rodvold, Thomas P. Kanyok, Steven J. Martin and Susan K. Chuck and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Transactions of the Royal Society of Tropical Medicine and Hygiene.

In The Last Decade

Chad R. Messick

15 papers receiving 255 citations

Peers

Chad R. Messick
G J Malanoski United States
Boris E. Reisberg United States
L. O. Gentry United States
Winter J. Smith United States
Jerome Santoro United States
G J Malanoski United States
Chad R. Messick
Citations per year, relative to Chad R. Messick Chad R. Messick (= 1×) peers G J Malanoski

Countries citing papers authored by Chad R. Messick

Since Specialization
Citations

This map shows the geographic impact of Chad R. Messick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad R. Messick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad R. Messick more than expected).

Fields of papers citing papers by Chad R. Messick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad R. Messick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad R. Messick. The network helps show where Chad R. Messick may publish in the future.

Co-authorship network of co-authors of Chad R. Messick

This figure shows the co-authorship network connecting the top 25 collaborators of Chad R. Messick. A scholar is included among the top collaborators of Chad R. Messick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad R. Messick. Chad R. Messick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Balasubramanian, Vijay, Chad R. Messick, Meredith Broderick, & Andrew C. Nelsen. (2018). Dosing characteristics of oral treprostinil in real‐world clinical practice. Pulmonary Circulation. 8(2). 1–4. 8 indexed citations
2.
Vizza, Carmine Dario, et al.. (2017). The impact of delayed treatment on 6-minute walk distance test in patients with pulmonary arterial hypertension: A meta-analysis. International Journal of Cardiology. 254. 299–301. 16 indexed citations
3.
Gotfried, Mark H., Rose Jung, Chad R. Messick, et al.. (2004). Effects of six-week clarithromycin therapy in corticosteroid-dependent asthma: A randomized, double-blind, placebo-controlled pilot study. Current Therapeutic Research. 65(1). 1–12. 17 indexed citations
4.
Pendland, Susan L., Chad R. Messick, & Rose Jung. (2002). In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa. Diagnostic Microbiology and Infectious Disease. 42(1). 75–78. 16 indexed citations
5.
Pendland, Susan L., et al.. (2002). In vitro bactericidal activity of piperacillin, gentamicin, and metronidazole in a mixed model containing Escherichia coli, Enterococcus faecalis, and Bacteroides fragilis. Diagnostic Microbiology and Infectious Disease. 43(2). 149–156. 6 indexed citations
6.
Thakur, C.P., et al.. (2000). Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Transactions of the Royal Society of Tropical Medicine and Hygiene. 94(4). 432–433. 55 indexed citations
7.
Jung, Rose, Chad R. Messick, Susan L. Pendland, et al.. (2000). Postantibiotic Effects and Bactericidal Activities of Clarithromycin–14-Hydroxy-Clarithromycin, versus Those of Amoxicillin-Clavulanate, against Anaerobes. Antimicrobial Agents and Chemotherapy. 44(3). 778–779. 1 indexed citations
8.
Messick, Chad R., Keith A. Rodvold, & Susan L. Pendland. (1999). Modified time–kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations. Journal of Antimicrobial Chemotherapy. 44(6). 831–834. 13 indexed citations
9.
Messick, Chad R., Muhammad Mamdani, Ian R. McNicholl, et al.. (1998). Pharmacoeconomic Analysis of Ampicillin‐Sulbactam versus Cefoxitin in the Treatment of Intraabdominal Infections. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(1). 175–183. 16 indexed citations
10.
Martin, Steven J., et al.. (1998). Levofloxacin and Sparfloxacin: New Quinolone Antibiotics. Annals of Pharmacotherapy. 32(3). 320–336. 44 indexed citations
11.
Messick, Chad R., et al.. (1998). In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci. Diagnostic Microbiology and Infectious Disease. 32(2). 95–99. 1 indexed citations
12.
Messick, Chad R. & Susan L. Pendland. (1997). In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci. Diagnostic Microbiology and Infectious Disease. 29(3). 203–205. 17 indexed citations
13.
Fiscella, Richard G., et al.. (1997). Polyhexamethylene Biguanide (PHMB) in the Treatment of Experimental Fusarium Keratomycosis. Cornea. 16(4). 447???449–447???449. 19 indexed citations
14.
Messick, Chad R. & Larry H. Danziger. (1996). Therapeutic Modalities for Mechanical Cleansing of the Colon. Journal of the American Pharmaceutical Association (1996). 36(7). 439–442.
15.
Reinke, Christian & Chad R. Messick. (1994). Update on Clostridium difficile-induced colitis, part 2. American Journal of Health-System Pharmacy. 51(15). 1892–1901. 24 indexed citations
16.
Reinke, Christian & Chad R. Messick. (1994). Update on Clostridium difficile-induced colitis, Part 1. American Journal of Health-System Pharmacy. 51(14). 1771–1781. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026